BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36191479)

  • 1. Development of a mouse model for spontaneous oral squamous cell carcinoma in Fanconi anemia.
    Errazquin R; Page A; Suñol A; Segrelles C; Carrasco E; Peral J; Garrido-Aranda A; Del Marro S; Ortiz J; Lorz C; Minguillon J; Surralles J; Belendez C; Alvarez M; Balmaña J; Bravo A; Ramirez A; Garcia-Escudero R
    Oral Oncol; 2022 Nov; 134():106184. PubMed ID: 36191479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generating New FANCA-Deficient HNSCC Cell Lines by Genomic Editing Recapitulates the Cellular Phenotypes of Fanconi Anemia.
    Errazquin R; Sieiro E; Moreno P; Ramirez MJ; Lorz C; Peral J; Ortiz J; Casado JA; Roman-Rodriguez FJ; Hanenberg H; Río P; Surralles J; Segrelles C; Garcia-Escudero R
    Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33918752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Programmable bio-nanochip-based cytologic testing of oral potentially malignant disorders in Fanconi anemia.
    Floriano PN; Abram T; Taylor L; Le C; Talavera H; Nguyen M; Raja R; Gillenwater A; McDevitt J; Vigneswaran N
    Oral Dis; 2015 Jul; 21(5):593-601. PubMed ID: 25662766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fanconi anemia-isogenic head and neck cancer cell line pairs: A basic and translational science resource.
    Nguyen HT; Tang W; Webster ALH; Whiteaker JR; Chandler CM; Errazquin R; Roohollahi K; Fritzke M; Hoskins EE; Jonlin E; Wakefield L; Sullivan LB; Chen EY; Dorsman J; Brakenhoff R; Paulovich AG; Grompe M; Garcia-Escudero R; Wells SI; Smogorzewska A; Monnat RJ
    Int J Cancer; 2023 Jul; 153(1):183-196. PubMed ID: 36912284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of cytogenetic changes and chromosomal aneuploidy with fluorescent in situ hybridization in cytological specimens of oral cancers in Fanconi anemia-Proof of concept.
    Silva de Araujo BE; Velleuer E; Dietrich R; Pomjanski N; de Santana Almeida Araujo IK; Schlensog M; Wells SI; Dorsman JC; Schramm M
    Clin Exp Dent Res; 2022 Feb; 8(1):108-116. PubMed ID: 34854575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic amplification of Fanconi anemia complementation group A (FancA) in head and neck squamous cell carcinoma (HNSCC): Cellular mechanisms of radioresistance and clinical relevance.
    Hess J; Unger K; Orth M; Schötz U; Schüttrumpf L; Zangen V; Gimenez-Aznar I; Michna A; Schneider L; Stamp R; Selmansberger M; Braselmann H; Hieber L; Drexler GA; Kuger S; Klein D; Jendrossek V; Friedl AA; Belka C; Zitzelsberger H; Lauber K
    Cancer Lett; 2017 Feb; 386():87-99. PubMed ID: 27867017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation and molecular characterization of head and neck squamous cell lines of fanconi anemia patients.
    van Zeeburg HJ; Snijders PJ; Pals G; Hermsen MA; Rooimans MA; Bagby G; Soulier J; Gluckman E; Wennerberg J; Leemans CR; Joenje H; Brakenhoff RH
    Cancer Res; 2005 Feb; 65(4):1271-6. PubMed ID: 15735012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity in FANCG, FANCF and BRIP1 from head and neck squamous cell carcinoma of the oral cavity.
    Türke C; Horn S; Petto C; Labudde D; Lauer G; Wittenburg G
    Int J Oncol; 2017 Jun; 50(6):2207-2220. PubMed ID: 28440438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling salivary miRNA expression levels in Fanconi anemia patients - a pilot study.
    Tang KD; Amenábar JM; Schussel JL; Torres-Pereira CC; Bonfim C; Dimitrova N; Hartel G; Punyadeera C
    Odontology; 2024 Jan; 112(1):299-308. PubMed ID: 37458838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and molecular characteristics of squamous cell carcinomas from Fanconi anemia patients.
    van Zeeburg HJ; Snijders PJ; Wu T; Gluckman E; Soulier J; Surralles J; Castella M; van der Wal JE; Wennerberg J; Califano J; Velleuer E; Dietrich R; Ebell W; Bloemena E; Joenje H; Leemans CR; Brakenhoff RH
    J Natl Cancer Inst; 2008 Nov; 100(22):1649-53. PubMed ID: 19001603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NRF2 Activation in Trp53;p16-deficient Mice Drives Oral Squamous Cell Carcinoma.
    Hamad SH; Sellers RS; Wamsley N; Zolkind P; Schrank TP; Major MB; Weissman BE
    Cancer Res Commun; 2024 Feb; 4(2):487-495. PubMed ID: 38335300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer stem cells are enriched in Fanconi anemia head and neck squamous cell carcinomas.
    Wu J; Mu Q; Thiviyanathan V; Annapragada A; Vigneswaran N
    Int J Oncol; 2014 Dec; 45(6):2365-72. PubMed ID: 25340704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the spectrum of germline variation in Fanconi anemia genes among patients with head and neck carcinoma before age 50.
    Chandrasekharappa SC; Chinn SB; Donovan FX; Chowdhury NI; Kamat A; Adeyemo AA; Thomas JW; Vemulapalli M; Hussey CS; Reid HH; Mullikin JC; Wei Q; Sturgis EM
    Cancer; 2017 Oct; 123(20):3943-3954. PubMed ID: 28678401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutated
    Bertola N; Degan P; Cappelli E; Ravera S
    Cells; 2022 Jul; 11(15):. PubMed ID: 35954197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive molecular screening for oral precancer in Fanconi anemia patients.
    Smetsers SE; Velleuer E; Dietrich R; Wu T; Brink A; Buijze M; Deeg DJ; Soulier J; Leemans CR; Braakhuis BJ; Brakenhoff RH
    Cancer Prev Res (Phila); 2015 Nov; 8(11):1102-11. PubMed ID: 26276748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral cancer in Fanconi anemia: Review of 121 cases.
    Furquim CP; Pivovar A; Amenábar JM; Bonfim C; Torres-Pereira CC
    Crit Rev Oncol Hematol; 2018 May; 125():35-40. PubMed ID: 29650274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic characteristics of oral squamous cell carcinomas in Fanconi anemia.
    Hermsen MA; Xie Y; Rooimans MA; Meijer GA; Baak JP; Plukker JT; Arwert F; Joenje H
    Fam Cancer; 2001; 1(1):39-43. PubMed ID: 14574014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fanconi anemia group A and C double-mutant mice: functional evidence for a multi-protein Fanconi anemia complex.
    Noll M; Battaile KP; Bateman R; Lax TP; Rathbun K; Reifsteck C; Bagby G; Finegold M; Olson S; Grompe M
    Exp Hematol; 2002 Jul; 30(7):679-88. PubMed ID: 12135664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterozygosity for p53 (Trp53+/-) accelerates epithelial tumor formation in fanconi anemia complementation group D2 (Fancd2) knockout mice.
    Houghtaling S; Granville L; Akkari Y; Torimaru Y; Olson S; Finegold M; Grompe M
    Cancer Res; 2005 Jan; 65(1):85-91. PubMed ID: 15665282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia-Related Head and Neck Cancer.
    Montanuy H; Martínez-Barriocanal Á; Antonio Casado J; Rovirosa L; Ramírez MJ; Nieto R; Carrascoso-Rubio C; Riera P; González A; Lerma E; Lasa A; Carreras-Puigvert J; Helleday T; Bueren JA; Arango D; Minguillón J; Surrallés J
    Clin Cancer Res; 2020 Jun; 26(12):3044-3057. PubMed ID: 32005748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.